nicotinamide phosphoribosyltransferase ; Homo sapiens

828 Article(s)
Pub. Date
#Total Relationship(s)
1 8289818 Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994 Feb 1
2 11241162 Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 2001 Apr 1
3 14612543 FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 2003 Nov 1 7
4 15124023 Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004 May 2
5 15381699 The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 2004 Dec 3 1
6 15899942 Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2005 Oct 1
7 15930160 Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 2005 Jun 3
8 15947248 Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation. Circ Res 2005 Jul 8 6
9 16394088 Visfatin is an adipokine, but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab 2006 Mar 1
10 16636125 Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans. J Clin Endocrinol Metab 2006 Jul 2
11 16733497 Apelin and visfatin: unique "beneficial" adipokines upregulated in obesity? Med Sci Monit 2006 Jun 2
12 16735449 Free fatty acids normalize a rosiglitazone-induced visfatin release. Am J Physiol Endocrinol Metab 2006 Nov 7
13 16736128 The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 2006 Aug 4
14 16783373 Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme. Nat Struct Mol Biol 2006 Jul 6
15 16901503 Crystal structure of visfatin/pre-B cell colony-enhancing factor 1/nicotinamide phosphoribosyltransferase, free and in complex with the anti-cancer agent FK-866. J Mol Biol 2006 Sep 8 14
16 16922702 The visfatin gene is associated with glucose and lipid metabolism in a Chinese population. Diabet Med 2006 Sep 2
17 16956691 Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 2007 Apr 1
18 17003086 Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin. J Clin Endocrinol Metab 2006 Dec 1
19 17003355 Serum visfatin increases with progressive beta-cell deterioration. Diabetes 2006 Oct 2
20 17095854 Differential expression of drug-resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia. Acta Haematol 2007 2
21 17097017 Effects of fatty acid regulation on visfatin gene expression in adipocytes. Chin Med J (Engl) 2006 Oct 20 2
22 17142138 The effect of spironolactone on circulating adipocytokines in patients with type 2 diabetes mellitus complicated by diabetic nephropathy. Metabolism 2006 Dec 1
23 17177135 Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 2006 Nov 3
24 17235334 Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients. Clin Pharmacol Ther 2007 Apr 5
25 17237424 Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007 Feb 1 1
26 17268245 The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol 2007 Mar 18
27 17284735 Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. Am J Clin Nutr 2007 Feb 3
28 17307730 Extension of human cell lifespan by nicotinamide phosphoribosyltransferase. J Biol Chem 2007 Apr 13 10
29 17327330 Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance. Diabetes Care 2007 Mar 7
30 17334748 Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia 2007 May 1
31 17340225 Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int 2007 Mar 4
32 17378999 Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metabolism 2007 Apr 6
33 17416788 Visfatin response to glucose is reduced in women with gestational diabetes mellitus. Diabetes Care 2007 Jul 1
34 17429683 The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile. Pflugers Arch 2007 Sep 6
35 17543285 Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway. Biochem Biophys Res Commun 2007 Jul 27 1
36 17556870 Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome. J Endocrinol Invest 2007 Apr 2
37 17565174 Crystallization of human nicotinamide phosphoribosyltransferase. Acta Crystallogr Sect F Struct Biol Cryst Commun 2007 May 1 7
38 17582143 Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum Reprod 2007 Jul 1
39 17587391 Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3-L1 pre-adipocytes and adipocytes. Diabetes Obes Metab 2007 Jul 9
40 17618961 Serum concentration of visfatin in obese women. Metabolism 2007 Aug 2
41 17697864 The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women. Metabolism 2007 Sep 1
42 17878256 Molecular characteristics of serum visfatin and differential detection by immunoassays. J Clin Endocrinol Metab 2007 Dec 2
43 17889652 Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 2007 Sep 21 3
44 17925464 Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass. Obesity (Silver Spring) 2007 Oct 2
45 17931620 Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia. Eur J Pharmacol 2008 Jan 14 3
46 17940983 Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans. Endokrynol Pol 2007 May-Jun 1
47 17952841 Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -- results from the PIOSTAT study. Horm Metab Res 2007 Oct 4
48 17983577 Nampt/PBEF/Visfatin: a new player in beta cell physiology and in metabolic diseases? Cell Metab 2007 Nov 5
49 18031315 Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin. Clin Endocrinol (Oxf) 2008 Feb 3
50 18034779 Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol (Oxf) 2008 Jul 3